Critical Care
(Jul 2020)
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience
- Ulrike Heinicke,
- Elisabeth Adam,
- Michael Sonntagbauer,
- Andreas von Knethen,
- Kai Zacharowski,
- Holger Neb
Affiliations
- Ulrike Heinicke
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt
- Elisabeth Adam
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt
- Michael Sonntagbauer
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt
- Andreas von Knethen
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt
- Kai Zacharowski
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt
- Holger Neb
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt
- DOI
-
https://doi.org/10.1186/s13054-020-03143-7
- Journal volume & issue
-
Vol. 24,
no. 1
pp.
1
– 4
WeChat QR code
